Article - 03/12/2009 Matthias Giese: DNA vaccine to combat worldwide honeybee deaths Varroa mites attach to the body of bees and weaken them by sucking hemolymph infecting them with viruses that are believed to be the cause of the mass death of European honeybee colonies. Matthias Giese of the Heidelberg-based Institute for Molecular Vaccines developed a DNA vaccine that might just lead to a breakthrough in the quest to get rid of the Varroa parasites. Giese tells us about his project in the following interview.https://www.gesundheitsindustrie-bw.de/en/article/news/matthias-giese-dna-vaccine-to-combat-worldwide-honeybee-deaths
Press release - 03/12/2009 Vetter to open new facility in suburban Chicago On 1st December 2009, the Ravensburg-based contract manufacturer Vetter dedicated its new production facility which will focus on early clinical projects. At the new site in Chicago, Vetter Development Services USA, Inc. will fill very small quantities of product required for pre-clinical through Phase IIb projects. Phase III projects and commercial large-scale production will in future be conducted by the company’s German facilities in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-to-open-new-facility-in-suburban-chicago
Press release - 01/12/2009 Treating gene defects with enzymes The American biotechnology company Genzyme has its German company site in the Stromeyersdorf industrial area in Constance where 26 Genzyme staff service the Eastern European and Central Asian markets. 35 other staff man local offices in Russia Romania Bulgaria Serbia Bosnia-Herzegovina and the Ukraine in order to boost the companys Eastern European business All the overseas staff speak the local language of the country where they are based.https://www.gesundheitsindustrie-bw.de/en/article/press-release/treating-gene-defects-with-enzymes
Article - 01/12/2009 Ralf Takors – a bio-engineer Multidisciplinary talent, people who can combine biological knowledge in an outstanding way with engineering, is in great demand. Ralf Takors, who has been head of the Institute of Bioprocess Engineering (IBVT) at the University of Stuttgart since July 2009, is one such talent. https://www.gesundheitsindustrie-bw.de/en/article/news/ralf-takors-a-bio-engineer
Press release - 01/12/2009 Stefan Wiemann elected new spokesman of the German Genome Research Network Associate Professor (PD) Dr. Stefan Wiemann of the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) has been elected spokesman of the Project Committee of the National Genome Research Network. This funding programme supports projects in medical genome research aimed at fighting relevant widespread diseases. https://www.gesundheitsindustrie-bw.de/en/article/press-release/stefan-wiemann-elected-new-spokesman-of-the-german-genome-research-network
Article - 01/12/2009 Preventative action for health A dense network of laws and directives provides information on environmental factors relating to when and in what quantities they can be tolerated and when they start to become a risk to human health. Comprehensive and precise analyses are required to conform with threshold values. Testing laboratories such as the Stuttgart-based UIS Umweltinstitut synlab GmbH carry out such analyses.https://www.gesundheitsindustrie-bw.de/en/article/news/preventative-action-for-health
Article - 30/11/2009 The problem children of protein biochemistry A large number of cellular proteins are located in or on a membrane. Dr. Dirk Schneider from the University of Freiburg believes that biochemists who investigate such proteins must be a little crazy, as the methods required to isolate the molecules from their exotic environment, i.e. from the lipid bilayer, are extremely difficult and complicated. Research has long focused on water-soluble proteins. Schneider and his team have now taken on the…https://www.gesundheitsindustrie-bw.de/en/article/news/the-problem-children-of-protein-biochemistry
Press release - 30/11/2009 Medical core business and acquisitions drive the success The HARTMANN GROUP increased its sales revenues by 12.5% to EUR 1,152 million in the first nine months of 2009, continuing the dynamic growth of the previous year. In the three medical core segments Wound Management, Incontinence Management and Infection Management, HARTMANN recorded sales growth of 15.2% and an increase in sales volume of 13.4%.https://www.gesundheitsindustrie-bw.de/en/article/press-release/medical-core-business-and-acquisitions-drive-the-success
Press release - 30/11/2009 Boehringer Ingelheim announces record productivities for CHO cells using the BI-HEX technology platform A team of Boehringer Ingelheim scientists reports another milestone in the development of the BI-HEX® technology platform. A record productivity of more than 100 picogramms per cell per day was achieved in inoculum and fed-batch cultures of BI-HEX® Chinese hamster ovary (CHO) cell lines expressing a therapeutic monoclonal antibody. https://www.gesundheitsindustrie-bw.de/en/article/press-release/boehringer-ingelheim-announces-record-productivities-for-cho-cells-using-the-bi-hex-technology-platf
Article - 30/11/2009 BioPharMaXX cluster to strengthen the Ulm region BioRegionUlm recently announced the launch of BioPharMaXX at a meeting held in Ummendorf castle (close to Ulm). The acronym refers to a cluster focusing on biotechnology, pharmacy and medical technology that was selected as one of twelve regional clusters in a state-wide contest in Baden-Württemberg in 2008. Company representatives and researchers presented projects to improve the time-consuming and costly protein purification process used in…https://www.gesundheitsindustrie-bw.de/en/article/news/biopharmaxx-cluster-to-strengthen-the-ulm-region
Article - 28/11/2009 "You cannot afford to fail twice in Germany" Prof. Dr. Bodo Liedvogel and Dr. Heinz Haubruck founded the company DIARECT AG in Freiburg in 1998. They not only brought 20 years of experience in industry to the company but also their entire savings. In the following interview Dr. Heinz Haubruck tells Christoph Bächtle about the return investors expect from companies how to win over potential clients and the risks associated with setting up ones own business.https://www.gesundheitsindustrie-bw.de/en/article/news/you-cannot-afford-to-fail-twice-in-germany
Press release - 27/11/2009 Gene Mutations Underlying Risk for Parkinson's Disease Two genes containing mutations known to cause rare familial forms of parkinsonism are also associated with the more common, sporadic form of the disease where there is no family history, researchers have found. The finding came in the largest genome-wide association study (GWAS) reported to date involving Parkinson's disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-mutations-underlying-risk-for-parkinson-s-disease
Press release - 24/11/2009 New impulses for the prevention of cancer Professor Cornelia Ulrich has been director of the Preventive Oncology Division in the National Centre for Tumour Diseases (NCT) in Heidelberg since mid-September 2009. She also holds a professorship in the Department of Preventive Oncology at the German Cancer Research Centre in Heidelberg.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-impulses-for-the-prevention-of-cancer
Press release - 24/11/2009 Three new collaborative research centres in Baden-Württemberg The German Research Foundation (DFG) is set to establish 17 new collaborative research centres (SFBs) on 1st January 2010. Ten of the new SFBs will focus on life science research projects, and will initially be funded for a period of four years with a total of 78 million euros in funding. One of the SFBs will be established at the University of Freiburg. Six of the 17 new SFBs are SFB/Transregio projects involving researchers from several German…https://www.gesundheitsindustrie-bw.de/en/article/press-release/three-new-collaborative-research-centres-in-baden-wuerttemberg
Article - 24/11/2009 cytobox: cell line production in record time Until recently the generation of cell lines was a very costly and time-consuming process taking up to 14 weeks of time. Thanks to a worldwide unique format used by the Constance-based company cytobox this now has become a thing of the past. The newly established biotechnology company offers researchers and developers ready-to-use stable cell lines that require a record time of only 30 business days to produce. The companys cell lines are also…https://www.gesundheitsindustrie-bw.de/en/article/news/cytobox-cell-line-production-in-record-time
Dossier - 24/11/2009 Environmental medicine and biosensor technology Smog, chemicals in rivers, particular matter from copying machines in offices – human beings are exposed to many toxic influences. Environmental medical specialists are investigating the effect that these kinds of substances have at the same time as trying to find ways to reduce their influence on human health as much as possible. Molecular and cell biologists and even biotechnologists all have a key part to play in these efforts. On the one…https://www.gesundheitsindustrie-bw.de/en/article/dossier/environmental-medicine-and-biosensor-technology
Press release - 23/11/2009 GATC Biotech soon opens sequencing laboratory in London GATC Biotech Europes leading sequencing service provider for industrial and academic research announces that it will open a sequencing laboratory in London to provide scientists in UK and Ireland with single sample sequencing services. The GATC London Laboratory will be situated in the London BioScience Innovation Centre LBIC and will start operations on January 4 2010. https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-soon-opens-sequencing-laboratory-in-london
Article - 21/11/2009 “Big companies do not specialise enough” Dr. Aziz Cayli worked for many years for big biotechnology and pharmaceutical companies. In 2005 he took the path of independence and set up the company CELLCA based in Laupheim Germany. Here Cayli talks to Christoph Bächtle about the fact that having the right partners plays a decisive role in establishing a company.https://www.gesundheitsindustrie-bw.de/en/article/news/big-companies-do-not-specialise-enough
Article - 19/11/2009 Iwona Adamska helps plants exposed to light stress Light is a vital element for plants. They require light to carry out photosynthesis and to produce their body substance from inorganic substances such as water and carbon dioxide. On the other hand plants can also suffer from too much light. Plants have developed a number of protective mechanisms to survive light stress situations. The biologist Prof. Iwona Adamska from the University of Constance is looking closely into these protective…https://www.gesundheitsindustrie-bw.de/en/article/news/iwona-adamska-helps-plants-exposed-to-light-stress
Press release - 19/11/2009 TET Systems and Novo Nordisk sign license agreement TET Systems Holding GmbH & Co. KG (“TET Systems”), a worldwide leader in controlled gene expression, today announced that TET Systems and Novo Nordisk A/S have signed a license agreement allowing the Hagedorn Research Institute (HRI), a research institute within Novo Nordisk A/S, the use of the Tet Technology for its internal research activities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tet-systems-and-novo-nordisk-sign-license-agreement
Article - 19/11/2009 Cellzome - kinase inhibitors for therapy Cellzome is a privately-owned biotechnology company which develops new drugs for the treatment of rheumatoid arthritis, multiple sclerosis and chronic inflammatory intestinal diseases at its two company sites in Heidelberg (Germany) and Cambridge (UK).https://www.gesundheitsindustrie-bw.de/en/article/news/cellzome-kinase-inhibitors-for-therapy
Press release - 19/11/2009 New scientific spokesperson of the German Society for Regenerative Medicine At this year’s general meeting of the German Society for Regenerative Medicine (GRM), Prof. Dr. Guido Nikkhah, Medical Director of the Department of Stereotactic Neurosurgery at the Neurocentre of the Freiburg University Medical Centre, was unanimously elected new scientific spokesperson of the GRM.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-scientific-spokesperson-of-the-german-society-for-regenerative-medicine
Press release - 17/11/2009 iGEM team Freiburg: a standing order for gold medals The Bioware team from Freiburg, an important part of the bioss cluster of excellence, has once again achieved resounding success: one gold medal and two special prizes at the iGEM competition (international Genetically Engineered Machine), the largest event for up-and-coming scientists focusing on synthetic biology. It was the turn of the research group heads, junior professor Dr. Kristian Müller and Dr. Katja Arndt, to participate in the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/igem-team-freiburg-a-standing-order-for-gold-medals
Press release - 17/11/2009 More precise radiation therapy with real-time movement detection The innovative tracking technology designed to increase the precision and efficiency of radiotherapy treatment that was developed by mediri GmbH (Heidelberg), winner of the BMBF’s Medical Technology Innovation Competition in 2006, has now been used for the first time. The technology has been integrated into a specifically developed ultrasound system belonging to the Fraunhofer Institute for Biomedical Technology (IBMT, St. Ingbert). https://www.gesundheitsindustrie-bw.de/en/article/press-release/more-precise-radiation-therapy-with-real-time-movement-detection
Article - 16/11/2009 New network for systems biology seed research What happens to plant seeds during germination? Researchers led by Dr. Gerhard Leubner from the University of Freiburg in collaboration with six international groups of researchers will be jointly looking into these processes. The virtual Seed (vSEED) consortium took first place in a field of 54 contestants in the European Research Era-Net Plant Genomics competition. What makes the scientists’ project so special is that they are planning to…https://www.gesundheitsindustrie-bw.de/en/article/news/new-network-for-systems-biology-seed-research